Rare diseases
Investigational molecules
Locations
Testing dapagliflozin to slow kidney function decline in patients with autosomal dominant polycystic kidney disease
GermanyStudy of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy
GermanyA Study of Repinatrabit Compared to Placebo for Treatment of Patients with Phenylketonuria
GermanyTesting dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression
GermanyA Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment
GermanyA study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer
GermanyA Study of TGD001 in Patients with Acute Ischemic Stroke to Test Safety and Effectiveness
GermanyA Study of Allo-QuadCAR01-T Cell Therapy for Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
GermanyStudy of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant
GermanyA Study of Tulisokibart for Adults with Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)
GermanyStudy of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer
GermanyStudy of mezigdomide and elranatamab combination treatment for patients with relapsed or refractory multiple myeloma
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
